These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35412608)

  • 61. Early Initiation of Plasma Exchange Therapy for Anti-MDA5
    Sasaki N; Nakagome Y; Kojima A; Shimura K; Ishii A; Sugiyama M; Izumi Y; Hirano K; Kurabayashi T; Hosono Y; Yamada C; Sato S
    Intern Med; 2024 Jan; 63(2):213-219. PubMed ID: 37225493
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease.
    Gui X; Shenyun S; Ding H; Wang R; Tong J; Yu M; Zhao T; Ma M; Ding J; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2022 Nov; 61(11):4570-4578. PubMed ID: 35148366
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of Patients With Dermatomyositis According to Anti-Melanoma Differentiation-Associated Gene-5 Autoantibodies in Centers from 3 Latin American Countries: A Cohort Study.
    Olivo Pallo PA; Hoff LS; Borges IBP; Torres-Ruiz J; Cassiano-Quezada F; Granel A; Gomez G; Pisoni C; Gomez R; Shinjo SK
    J Clin Rheumatol; 2022 Mar; 28(2):e444-e448. PubMed ID: 34262005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment.
    Shirakashi M; Nakashima R; Tsuji H; Tanizawa K; Handa T; Hosono Y; Akizuki S; Murakami K; Hashimoto M; Yoshifuji H; Ohmura K; Mimori T
    Rheumatology (Oxford); 2020 Nov; 59(11):3284-3292. PubMed ID: 32276271
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositis.
    Wang C; Yang H; Li T; Wen Y; Yang H; Tang W; Li L; Sun S
    Clin Respir J; 2023 Dec; 17(12):1328-1340. PubMed ID: 37985458
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study.
    Zhou S; Lai J; Wu C; Liu Y; Liu Y; Zhao J; Xu D; Tian X; Li M; Zhao Y; Wang Y; Wang Q; Zeng X
    Front Immunol; 2022; 13():928861. PubMed ID: 35983058
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
    Yamaguchi K; Yamaguchi A; Itai M; Kashiwagi C; Takehara K; Aoki S; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Takemura M; Hara K; Motegi SI; Muro Y; Nakasatomi M; Sakairi T; Hiromura K; Kurabayashi M; Maeno T
    Clin Rheumatol; 2019 Dec; 38(12):3443-3450. PubMed ID: 31420814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study.
    Wu W; Xu W; Sun W; Zhang D; Zhao J; Luo Q; Wang X; Zhu F; Zheng Y; Xue Y; Wan W; Wu H; Han Q; Ye S
    Rheumatology (Oxford); 2021 Dec; 61(1):230-239. PubMed ID: 33764398
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
    Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y
    J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
    Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
    Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.
    Jin Q; Fu L; Yang H; Chen X; Lin S; Huang Z; Gao B; Tian X; Jiang W; Shu X; Lu X; Wang G; Peng Q
    J Intern Med; 2023 Apr; 293(4):494-507. PubMed ID: 36682032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease.
    Xu YT; Zhang YM; Yang HX; Ye LF; Chen F; Lu X; Wang GC; Peng QL
    Rheumatology (Oxford); 2022 Dec; 62(1):397-406. PubMed ID: 35412602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease.
    Lian X; Ye Y; Zou J; Wu C; Ye S; Guo Q; Chen S; Lu L; Wang R; Fu Q; Bao C
    Rheumatology (Oxford); 2023 May; 62(5):1910-1919. PubMed ID: 36130290
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical risk factors in patients with interstitial lung disease associated with anti-MDA5 autoantibodies.
    Ramos-Martinez E; Rodríguez-Vega EA; Rivera-Matias PA; Falfán-Valencia R; Pérez-Rubio G; Mejia M; González-Pérez MI; Buendia-Roldán I; Mateos-Toledo HN; Serrano JR
    Med Clin (Barc); 2023 Dec; 161(12):515-522. PubMed ID: 37567825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China.
    You H; Wang L; Wang J; Lv C; Xu L; Yuan F; Li J; Wu M; Zhou S; Da Z; Qian J; Wei H; Yan W; Zhou L; Wang Y; Yin S; Zhou D; Wu J; Lu Y; Su D; Liu Z; Liu L; Ma L; Xu X; Zang Y; Liu H; Ren T; Wang F; Zhang M; Tan W
    Rheumatology (Oxford); 2023 Mar; 62(3):1216-1226. PubMed ID: 35961045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X; Li A; Li C
    Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.
    Chen F; Wang D; Shu X; Nakashima R; Wang G
    Rheumatol Int; 2012 Dec; 32(12):3909-15. PubMed ID: 22198664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.